Liraglutide has less adverse cardiovascular outcomes than placebo

    loading  Checking for direct PDF access through Ovid

Abstract

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016; 375(4):311–322.

Related Topics

    loading  Loading Related Articles